抗精神病药对伴精神病性特征抑郁症功能连接的影响
本研究纳入伴精神病性特征的重性抑郁障碍(MDDPsy)患者,所有参与者先接受舍曲林联合奥氮平治疗,随后随机分为继续舍曲林联合奥氮平或换用舍曲林联合安慰剂两组,在随机化时和研究终点完成MRI。结果显示,继续奥氮平组次级视觉网络与大脑其余区域的功能连接未变,而换用安慰剂组该连接下降,提示奥氮平可能稳定功能连接。
要点
- 伴精神病性特征MDD患者中,奥氮平可能稳定次级视觉网络与全脑的功能连接。
- 继续奥氮平组与换用安慰剂组在网络拓扑图指标变化上无显著差异。
- 研究样本量有限,功能连接分析仅58例可用,结论需谨慎解读。
核心结论
- 奥氮平可能稳定伴精神病性特征重性抑郁障碍患者次级视觉网络与大脑其余区域的功能连接。
研究设计与样本
- 研究为随机化临床试验的事后MRI分析,患者来自精神病性抑郁药物治疗研究II(Study of the Pharmacotherapy of Psychotic Depression II)。
- 所有参与者先接受舍曲林联合奥氮平治疗,随后随机分为继续舍曲林联合奥氮平组或换用舍曲林联合安慰剂组。
主要发现
- 次级视觉网络与大脑其余区域功能连接存在显著的治疗×时间交互作用(t = -3.684;p = 0.0004;pFDR = 0.0111)。
- 继续奥氮平组次级视觉网络与大脑其余区域的功能连接未变,而换用安慰剂组该连接下降。
- 图度量(graph metrics)的网络拓扑指标未见显著的治疗×时间交互作用。
关键数值与推荐
- 主要结局为指定网络内部及与大脑其余区域功能连接的变化。
- 次要结局为图度量评估的网络拓扑变化。
- 功能连接分析显示次级视觉网络与全脑连接的治疗×时间交互作用显著(t = -3.684;p = 0.0004;pFDR = 0.0111)。
临床怎么用
- 对于伴精神病性特征的重性抑郁障碍患者,继续奥氮平治疗可能有助于维持次级视觉网络与全脑的功能连接稳定性。
- 换用安慰剂后该功能连接下降,提示临床决策中需关注抗精神病药撤药对脑功能连接的潜在影响。
局限性
- 随访扫描完成73例,仅58例可用于分析,样本量有限。
- 研究为随机化试验的事后分析,功能连接结果需在独立样本中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The effect of antipsychotic medication on resting state functional connectivity in major depressive disorder (MDD) is currently unknown. To address this gap, we examined patients with MDD with psychotic features (MDDPsy) participating in the Study of the Pharmacotherapy of Psychotic Depression II. All participants were treated with sertraline plus olanzapine and were subsequently randomized to continue sertraline plus olanzapine or be switched to sertraline plus placebo. Participants completed an MRI at randomization and at study endpoint (study completion at Week 36, relapse, or early termination). The primary outcome was change in functional connectivity measured within and between specified networks and the rest of the brain. The secondary outcome was change in network topology measured by graph metrics. Eighty-eight participants completed a baseline scan; 73 completed a follow-up scan, of which 58 were usable for analyses. There was a significant treatment X time interaction for functional connectivity between the secondary visual network and rest of the brain (t = -3.684; p = 0.0004; pFDR = 0.0111). There was no significant treatment X time interaction for graph metrics. Overall, functional connectivity between the secondary visual network and the rest of the brain did not change in participants who stayed on olanzapine but decreased in those switched to placebo. There were no differences in changes in network topology measures when patients stayed on olanzapine or switched to placebo. This suggests that olanzapine may stabilize functional connectivity, particularly between the secondary visual network and the rest of the brain.
引用
- Neufeld NH, Oliver LD, Mulsant BH, et al. Effects of antipsychotic medication on functional connectivity in major depressive disorder with psychotic features. Mol Psychiatry. 2023. PMID: 37258617. doi:10.1038/s41380-023-02118-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。